[1]
Sagarkumar Patel et al. 2023. IMMUNOGENICITY IN PRECLINICAL DRUG DEVELOPMENT: STRATEGIES, RISKS, AND IMPLICATIONS FOR LARGE MOLECULE-BASED BIOLOGICS INCLUDING CAR T-CELL AND GENE THERAPIES. Journal of Population Therapeutics and Clinical Pharmacology. 30, 3 (Mar. 2023), 786–802. DOI:https://doi.org/10.53555/jptcp.v30i3.2784.